Nabumetone Tablet
Product Images NDC 71335-1559

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 71335-1559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph depicting Nabumetone active metabolite (6MNA) plasma concentrations over 70 hours at steady state following once-daily dosing of Nabumetone at 1000 mg (n=31) and 2000 mg (n=12). The graph shows concentration ranges with +2 and -2 standard deviations for both dosages over time in hours.*

FDA Label Image

Label (Lbl713351559)

Nabumetone 750 mg tablet label by Bryant Ranch Prepack. The label includes a comparison to Relafen 750 mg tablet by ScieGen Pharmaceuticals Inc. It specifies a count of 60 tablets, an NDC of 71335-1559-1, and lot number 1523487. Instructions include taking with food and storage at room temperature (20°-25°C). The label also advises keeping all drugs out of reach of children.*

FDA Label Image

Structure1 (Structure1)

Chemical structure of Nabumetone showing its molecular formula C15H16O2 and molecular weight 228.3, with distinct aromatic rings and side chains.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone. The diagram shows a naphthalene ring with a methoxy group and an acetic acid side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.